|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
University of Pennsylvania Bill and Melinda Gates Foundation |
| Information provided by: | University of Pennsylvania |
| ClinicalTrials.gov Identifier: | NCT00194272 |
Purpose
This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.
| Condition | Intervention | Phase |
|
Ectopic Pregnancy |
Drug: Methotrexate |
Phase III |
| Genetics Home Reference related topics: | Brugada syndrome short QT syndrome |
| ChemIDplus related topics: | Methotrexate |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Two-Dose Methotrexate for Ectopic Pregnancy |
| Enrollment: | 100 |
| Study Start Date: | March 2001 |
| Study Completion Date: | June 2007 |
The regimen is an attempt to create a middle ground between the 2 commonly used regimens - "single dose" and "multi dose". The "multi dose" regimen is more effective, but the "single dose" regimen is more convenient for patients and has fewer side effects.
Eligibility
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Confirmed diagnosis of ectopic pregnancy via
Exclusion Criteria:
Contacts and Locations| United States, California | |||||
| University of Southern California Women's and Children's Hospital | |||||
| Los Angeles, California, United States, 90033 | |||||
| United States, Florida | |||||
| University of Miami | |||||
| Miami, Florida, United States, 33101 | |||||
| United States, Pennsylvania | |||||
| University of Pennsylvania Reproductive Research Unit | |||||
| Philadelphia, Pennsylvania, United States, 19104 | |||||
| University of Pennsylvania |
| Bill and Melinda Gates Foundation |
| Principal Investigator: | Kurt T Barnhart, MD, MSCE | University of Pennsylvania |
More Information
| Responsible Party: | University of Pennsylvania ( Kurt T Barnhart, MD, MSCE ) |
| Study ID Numbers: | 701460, RRU001 |
| First Received: | September 13, 2005 |
| Last Updated: | July 26, 2008 |
| ClinicalTrials.gov Identifier: | NCT00194272 |
| Health Authority: | United States: Food and Drug Administration |
|
|
|
|
|